The World Market For Dairy Bioactive Ingredients 2009-2012

A new report on dairy-derived bioactive ingredients, named The World Market for Dairy Bioactive Ingredients 2009-2012, clearly demonstrates increasing activity within this business area. The product range continues to expand, more patents are issued, the number of new consumer products launched containing these bioactives is continuously increasing, and the current market size estimated to more than 30,000 MT with an approximate value of USD 700 million is growing by 10-20% p.a.

The market for dairy bioactives is being driven by the broader nutrition industry, i.e. infant formula, sports nutrition, dietary supplements, clinical nutrition and functional foods.

The major players are the large dairy ingredient companies with significant technological depth and global market reach, e.g. Arla Foods, FrieslandCampina, Davisco, Glanbia, Fonterra and Morinaga/Milei. From the non-dairy area, DSM is the most prominent player marketing a couple of milk-derived bioactive peptides.

"The dairy bioactive ingredient business is a high risk – high reward business area, as it takes considerable knowledge and resources in processing technologies, regulatory aspects including claims and marketing capability to be successful" says Tage Affertsholt, Managing Partner in 3A Business Consulting.

The report is global in scope and covers a wide range of ingredients such as milk and whey hydrolysates, peptides, glycomacropeptides, caseinphosphopeptides, ?-lactalbumin, ?-lactoglobulin, immunoglobulins, lactoferrin, osteopontin, milk phospholipids etc.

Report headlines are:

• Market size (volume and value) and expected growth
• Current applications and new product development trends
• Historical and current price developments
• Producer profiles
• Application and breakdown of end-use segments
• Drivers and barriers
• Regulatory issues
• Patent activity within the given product areas

"Generelly, bioactives addressing the current key health issues have excellent growth opportunities, and dairy-derived bioactives will be part of the solution in the future", says Tage Affertsholt.

SOURCE: The World Market